AllianceBernstein
ALXO icon

AllianceBernstein’s ALX Oncology ALXO Stock Holding History

AllianceBernstein’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-71,730
Closed -$44.7K – 3236
2025
Q1 		$44.7K Hold
71,730
– – ﹤0.01% 3143
2024
Q4 		$120K Hold
71,730
– – ﹤0.01% 3109
2024
Q3 		$131K Hold
71,730
– – ﹤0.01% 3100
2024
Q2 		$433K Buy
71,730
+32,940
+85% +$405K ﹤0.01% 2743
2024
Q1 		$433K Sell
38,790
-1,500
-4% -$21.1K ﹤0.01% 2643
2023
Q4 		$600K Hold
40,290
– – ﹤0.01% 2520
2023
Q3 		$193K Buy
40,290
+1,710
+4% +$9.28K ﹤0.01% 2977
2023
Q2 		$290K Buy
38,580
+8,580
+29% +$56.2K ﹤0.01% 2878
2023
Q1 		$136K Buy
30,000
+1,500
+5% +$11.4K ﹤0.01% 2982
2022
Q4 		$321K Buy
28,500
+3,100
+12% +$34.8K ﹤0.01% 2843
2022
Q3 		$243K Sell
25,400
-2,400
-9% -$28K ﹤0.01% 2955
2022
Q2 		$225K Buy
27,800
+7,300
+36% +$79.5K ﹤0.01% 2987
2022
Q1 		$346K Hold
20,500
– – ﹤0.01% 2829
2021
Q4 		$441K Sell
20,500
-3,000
-13% -$129K ﹤0.01% 2796
2021
Q3 		$1.74M Hold
23,500
– – ﹤0.01% 2242
2021
Q2 		$1.28M Buy
23,500
+1,100
+5% +$65.8K ﹤0.01% 2425
2021
Q1 		$1.65M Buy
22,400
+7,600
+51% +$598K ﹤0.01% 2200
2020
Q4 		$1.28M Buy
+14,800
New +$890K ﹤0.01% 2202

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AllianceBernstein's ALXO Position: Q2 2025 in Review

AllianceBernstein sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 71,730 shares — an estimated $44.7K sold.

AllianceBernstein first reported a position in ALXO in Q4 2020 and held it in 18 quarters. The position peaked at $1.74M in Q3 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • AllianceBernstein reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 71,730 ALX Oncology shares in Q2 2025, an estimated $44.7K.
  • AllianceBernstein first reported a position in ALX Oncology in Q4 2020 and held it in 18 quarters.
  • AllianceBernstein's ALX Oncology position peaked at $1.74M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.